TruBridge Faces Investor Lawsuit Investigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TBRG?
Source: Globenewswire
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
- Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 15.380
Low
21.00
Averages
22.00
High
23.00
Current: 15.380
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
TruBridge Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
- Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, exposing shareholders to possible securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ending December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, reflecting market concerns regarding the company's financial transparency and credibility.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for investor losses, allowing participation without upfront fees, highlighting the uncertainty surrounding TruBridge's future financial health.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Earnings Release Postponed: TruBridge has postponed its fourth quarter and year-end 2025 earnings release, originally scheduled for March 16, 2026, resulting in an 8% drop in shares during Tuesday's premarket trading, indicating market concerns over financial transparency.
- Audit Procedure Delays: The delay is attributed to the need for additional time to complete year-end audit procedures, particularly after errors were identified in the 2024 financial statements related to revenue, software development costs, and share-based payments, which could impact investor confidence.
- Financial Statement Revisions: TruBridge will revise its previously issued consolidated financial statements for 2024, although the company asserts that these errors did not result in a material misstatement and are non-cash in nature, indicating a focus on maintaining financial health.
- Market Reaction Analysis: The postponement and disclosure of financial errors may lead to investor skepticism regarding TruBridge's future performance, especially as the company seeks to restore market trust, potentially affecting its stock price and financing capabilities.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Financial Statement Errors: TruBridge identified errors in its consolidated financial statements for the year ended December 31, 2024, and out-of-period errors for all three quarters of 2025, primarily related to revenue accounting, software development costs, and share-based payments, although these did not result in material misstatements, necessitating additional audit time.
- Earnings Release Postponed: The company announced the postponement of its fourth-quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, indicating a cautious approach to completing its audit procedures, with expectations to file by March 31, 2026.
- Stock Price Reaction: Following the announcement, TruBridge's shares fell over 5%, reflecting market concerns regarding financial transparency and the delay in auditing, with a total decline of 25% in 2026 thus far.
- Market Sentiment: Despite the stock decline, retail sentiment around TruBridge remains neutral amid high message volume, indicating investor focus on the company's future financial health and performance expectations.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Earnings Release Postponed: TruBridge has announced the postponement of its fourth quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, to allow for the completion of year-end audit procedures, which may impact investor confidence.
- Financial Statement Errors: Errors were identified in the consolidated financial statements for 2024 and several quarters of 2025, primarily related to revenue recognition and software development costs, necessitating revisions to the 2024 financial statements, although the company believes these errors do not materially affect its financial position.
- Internal Control Deficiencies: TruBridge has identified deficiencies in internal controls over financial reporting, which management has deemed material weaknesses as of December 31, 2025, potentially affecting future financial transparency and compliance, necessitating strengthened internal control processes.
- Future Outlook: TruBridge expects to file its 2025 Form 10-K within the 15-day extension period granted by the SEC; despite facing audit delays, the company is committed to improving its financial reporting processes to ensure future compliance and accuracy.
See More
TruBridge to Release Q4 and Year-End 2025 Financial Results
- Earnings Release Schedule: TruBridge, Inc. will announce its Q4 and full-year 2025 financial results on March 16, 2026, after market close, reflecting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will host a conference call at 3:30 PM Central Time (4:30 PM Eastern Time) on the same day, providing an opportunity for direct interaction between investors and management, which can enhance investor confidence.
- Online Broadcast and Replay: The conference call will be available via live broadcast on the company's investor relations website, with a 30-day replay offered post-event, ensuring that investors who cannot attend live can still access critical information.
- Company Background: With over 45 years of healthcare experience, TruBridge is dedicated to supporting rural and community hospitals by offering a range of technology and services, including revenue cycle management and electronic health records, emphasizing its vital role in community healthcare.
See More
TruBridge Faces Investor Lawsuit Investigation
- Legal Investigation Initiated: Bragar Eagel & Squire, P.C. is investigating TruBridge, Inc. (NASDAQ:TBRG) for potential violations of federal securities laws and other unlawful business practices, indicating significant legal risks that could impact the company's market reputation.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 revealing its inability to timely submit its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may lead to decreased investor confidence in the company's financial transparency.
- Significant Stock Price Drop: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's future performance and stability.
- Investor Rights Advocacy: Bragar Eagel & Squire encourages affected investors to contact their attorneys to discuss legal rights, demonstrating a proactive approach to protecting investor interests, which may influence the trajectory of future legal proceedings.
See More
TruBridge Faces Securities Claims Investigation
- Securities Claims Investigation: Rosen Law Firm has announced an investigation into TruBridge, Inc. (NASDAQ: TBRG) due to potential issuance of materially misleading business information, exposing shareholders to possible securities claims.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely file its Annual Report for the fiscal year ending December 31, 2025, citing the identification of errors in previously issued financial statements requiring further analysis.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share on March 17, 2026, reflecting market concerns regarding the company's financial transparency and credibility.
- Class Action Preparation: The Rosen Law Firm is preparing a class action to seek compensation for investor losses, allowing participation without upfront fees, highlighting the uncertainty surrounding TruBridge's future financial health.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Earnings Release Postponed: TruBridge has postponed its fourth quarter and year-end 2025 earnings release, originally scheduled for March 16, 2026, resulting in an 8% drop in shares during Tuesday's premarket trading, indicating market concerns over financial transparency.
- Audit Procedure Delays: The delay is attributed to the need for additional time to complete year-end audit procedures, particularly after errors were identified in the 2024 financial statements related to revenue, software development costs, and share-based payments, which could impact investor confidence.
- Financial Statement Revisions: TruBridge will revise its previously issued consolidated financial statements for 2024, although the company asserts that these errors did not result in a material misstatement and are non-cash in nature, indicating a focus on maintaining financial health.
- Market Reaction Analysis: The postponement and disclosure of financial errors may lead to investor skepticism regarding TruBridge's future performance, especially as the company seeks to restore market trust, potentially affecting its stock price and financing capabilities.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Financial Statement Errors: TruBridge identified errors in its consolidated financial statements for the year ended December 31, 2024, and out-of-period errors for all three quarters of 2025, primarily related to revenue accounting, software development costs, and share-based payments, although these did not result in material misstatements, necessitating additional audit time.
- Earnings Release Postponed: The company announced the postponement of its fourth-quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, indicating a cautious approach to completing its audit procedures, with expectations to file by March 31, 2026.
- Stock Price Reaction: Following the announcement, TruBridge's shares fell over 5%, reflecting market concerns regarding financial transparency and the delay in auditing, with a total decline of 25% in 2026 thus far.
- Market Sentiment: Despite the stock decline, retail sentiment around TruBridge remains neutral amid high message volume, indicating investor focus on the company's future financial health and performance expectations.
See More
TruBridge Delays 2025 Year-End Earnings Release
- Earnings Release Postponed: TruBridge has announced the postponement of its fourth quarter and year-end 2025 earnings release originally scheduled for March 16, 2026, to allow for the completion of year-end audit procedures, which may impact investor confidence.
- Financial Statement Errors: Errors were identified in the consolidated financial statements for 2024 and several quarters of 2025, primarily related to revenue recognition and software development costs, necessitating revisions to the 2024 financial statements, although the company believes these errors do not materially affect its financial position.
- Internal Control Deficiencies: TruBridge has identified deficiencies in internal controls over financial reporting, which management has deemed material weaknesses as of December 31, 2025, potentially affecting future financial transparency and compliance, necessitating strengthened internal control processes.
- Future Outlook: TruBridge expects to file its 2025 Form 10-K within the 15-day extension period granted by the SEC; despite facing audit delays, the company is committed to improving its financial reporting processes to ensure future compliance and accuracy.
See More
TruBridge to Release Q4 and Year-End 2025 Financial Results
- Earnings Release Schedule: TruBridge, Inc. will announce its Q4 and full-year 2025 financial results on March 16, 2026, after market close, reflecting the company's commitment to transparency and investor communication.
- Conference Call Timing: The company will host a conference call at 3:30 PM Central Time (4:30 PM Eastern Time) on the same day, providing an opportunity for direct interaction between investors and management, which can enhance investor confidence.
- Online Broadcast and Replay: The conference call will be available via live broadcast on the company's investor relations website, with a 30-day replay offered post-event, ensuring that investors who cannot attend live can still access critical information.
- Company Background: With over 45 years of healthcare experience, TruBridge is dedicated to supporting rural and community hospitals by offering a range of technology and services, including revenue cycle management and electronic health records, emphasizing its vital role in community healthcare.
See More
